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ABSTRACT
Role of Macrophages in Ocular Surface Fibrosis
by Alyanna Beatrice Corpuz
The present study is designed to investigate whether irradiation as used for conditioning
regimen to ablate recipient’s diseased bone marrow prior to transplantation could trigger
macrophage activation and polarization and whether macrophages could cause the
transdifferentiation of ocular surface fibroblasts into myofibroblasts, thus contributing to
oGVHD-associated fibrosis.
Bone marrow cells were cultured in M-CSF to obtain M0 macrophages, which were
subsequently polarized into M1 and M2 phenotypes using IFN-g + LPS and IL-4, respectively.
The macrophages were exposed to 7 Gy radiation. The effect of irradiation on macrophage
activation markers, phagocytosis, and apoptosis was assessed using real-time PCR, confocal
microscopy, and flow cytometry. Ocular surface fibroblasts were co-cultured using membrane
inserts placed on top of cultured M0, M1, and M2 macrophages for 3 days. Myofibroblast
formation was assessed using a-SMA immunostaining and gene expression. The effect of
macrophages on profibrotic mediators in the fibroblasts was quantified using real-time PCR.
Finally, chemokine release from macrophages was analyzed using real-time PCR and bead-based
immunoassay.
Our data demonstrates successful generation of M0 macrophages and their polarization
into M1 and M2 phenotypes as confirmed by gene quantification and flow cytometry for
macrophage markers CD11b, F4/80, CD86, CD206, iNOS, and arginase-1. Our data
demonstrates that irradiation caused an increase in macrophage pro-inflammatory cytokines IL1b, TNF-a, and IL-6 and chemokine CCL2. While irradiation did not cause increase in M1
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markers, there was a robust increase in M2 markers. Furthermore, irradiation significantly
increased macrophage phagocytosis without compromising their viability. Our data also
demonstrates that M0 and M2 macrophages induced significant increase of a-SMA expression in
ocular surface fibroblasts and a concomitant notable increase in RAS components and TGF-b1
receptor, but no change in PDGF and M-CSF expression was noted. Finally, our data
demonstrates that both M1 and M2 macrophages showed increased gene expression and
secretion of chemokines CCL17 and CCL22.
In conclusion, our data demonstrates that macrophages could play a key role in the
pathology of oGVHD-associated fibrosis due to their likely activation in response to irradiation
and cross-talk with ocular surface fibroblasts, resulting in their transdifferentiation to
myofibroblasts.
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CHAPTER 1
INTRODUCTION
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The cornea and conjunctiva collectively constitute the ocular surface. Healthy ocular
surface is vital for normal vision. Noxious stimuli such as laser surgery, chemical or thermal
burns, physical or mechanical injury, radiation, or systemic diseases can cause injury to the
ocular surface leading to excessive wound healing response. Aberrant wound healing response
can result in corneal and conjunctival fibrosis. Consequent fibrotic changes in the cornea and
conjunctiva can severely impact vision, leading to significant morbidity and reduced quality of
life (Inamoto et al., 2019).
Fibrosis is marked by the accumulation of extracellular matrix (ECM) components.
Myofibroblasts, which transdifferentiate from activated fibroblasts, are responsible for the
deposition of ECM and dysregulated ECM production could lead to excessive tissue remodeling
and permanent scarring due to fibrosis (Distler et al., 2019). Fibrosis is highly prevalent in
chronic conditions associated with inflammation including scleroderma, Crohn’s disease,
systemic lupus erythematosus, and graft-versus-host disease (Wynn and Ramalingam, 2012).
Graft-versus-host disease (GVHD) is one of the main causes of morbidity and mortality
following allogeneic bone marrow transplantation in which donor marrow (graft) attacks the
host’s tissues. Prior to receiving a bone marrow transplant, patients must undergo a conditioning
regimen to ablate their diseased marrow using either total body irradiation or chemotherapy
drugs which can cause tissue injury and initiate wound healing response (Gyurkocza and
Sandmaier, 2014). GVHD is classified as either acute or chronic. In acute GVHD, the skin,
gastrointestinal tract, and the liver are severely impacted. In chronic GVHD, the clinical
manifestations can spread further into the mucosal surfaces in addition to the skin such as the
mouth, lungs, and eyes (Hill et al., 2021). Clinical reports have indicated that damage to the
ocular surface is highly prevalent in chronic GVHD, wherein particularly the conjunctiva is
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severely inflicted with fibrotic scarring (Kusne et al., 2017; Kheirkhah et al., 2018). Ocular
GVHD occurs in more than 60% of patients with chronic GVHD (Herretes et al., 2015).
Like all mucosal surfaces, the ocular surface also contains an innate immune system that
protects the eye from invading pathogens and maintains homeostasis. Both the cornea and
conjunctiva are endowed with macrophage and fibroblast populations. Macrophages are sentinel,
phagocytic cells of the innate immune system that are prominently involved in clearance of
cellular debris, dead cells, and pathogens. Macrophages also act as antigen-presenting cells.
Macrophages exhibit remarkable phenotypic plasticity and are known to release an array of proinflammatory or profibrotic cytokines (Mosser and Edwards, 2008). Macrophages can be
classified under two main phenotypes: M1 classically-activated, pro-inflammatory and M2
alternatively-activated, anti-inflammatory or profibrotic. M1 macrophages perform the
characteristic microbicidal host defense by producing pro-inflammatory mediators to induce an
inflammatory response. In contrast, M2 macrophages resolve inflammation and initiate wound
healing through secretion of anti-inflammatory and profibrotic mediators (Klopfleisch, 2016).
Macrophage activation has been implicated in several pathological conditions such as chronic
inflammatory and autoimmune diseases, cancer, and fibrosis (Wynn et al., 2013).
Studies have demonstrated that polarized macrophages contribute to the pathogenesis of
fibrosis. Unresolved inflammation could lead to exacerbation of tissue damage at the site of
injury as well as neighboring tissues. Consequently, chronic inflammation is accompanied by
excessive tissue restoration, which could be a result of activation of profibrotic signaling
pathways. Macrophages are sources of profibrotic mediators including TGF-b, components of
the renin-angiotensin system, platelet derived growth factor (PDGF) and connective tissue
growth factor (CTGF) (Wang et al., 2021). Thus, macrophage activation, phenotype change and
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the milieu of profibrotic cytokines and mediators can play a critical role in ocular surface
inflammation, wound healing, and fibrosis. Studies have also demonstrated that macrophages
could become activated and able to polarize preferentially toward either the pro-inflammatory or
anti-inflammatory phenotype upon radiation exposure. Additionally, it has been observed that
macrophages may show resistance toward radiation and may not undergo cellular death. (Teresa
Pinto et al., 2016; Wu et al., 2017).
Currently, there are no studies that investigate how noxious stimuli such as irradiation
can affect macrophage activation and phenotype changes, which in turn can modulate ocular
surface fibroblasts to contribute to ocular surface fibrosis in the context of ocular GVHD. Thus,
the present study is designed to investigate whether irradiation as used as a conditioning regimen
for bone marrow ablation prior to transplantation could trigger macrophage activation and
polarization. Further, this study also investigates whether macrophage activation, polarization,
and associated upregulation of profibrotic pathways could potentially cause the
transdifferentiation of ocular surface fibroblasts into myofibroblasts, thus contributing to ocular
surface fibrosis. We will test this hypothesis using the following aims:
Aim 1: To determine whether exposing macrophages to radiation affects macrophage
activation, polarization, and phagocytosis.
Aim 2: To identify whether polarized macrophages can cause ocular surface fibroblast
transdifferentiation to myofibroblasts and can modulate profibrotic pathways in these fibroblasts.
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CHAPTER 2
REVIEW OF
LITERATURE
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Ocular Surface Injury and Fibrosis
i. Tissue Injury & Fibrosis
Tissue damage could arise from a variety of causes including mechanical or chemical
injury, infections, autoimmune reactions, radiation and systemic diseases-associated with chronic
inflammation. Tissue injury initiates an inflammatory response that activates innate immunity,
which involves the infiltration, clearance of tissue debris, and release of pro-inflammatory
mediators by leukocytes such as macrophages and neutrophils. These immune cells also release
profibrotic mediators that could activate and induce the transdifferentiation of fibroblasts into
myofibroblasts leading to fibrosis.
Fibrosis can occur in virtually every tissue and organ and is also prevalent in chronic
systemic diseases causing tissue injury due to inflammation including atherosclerosis, kidney
disease, chronic obstructive pulmonary disease, and graft-versus-host disease. Wound healing
involves two phases: regeneration and fibroplasia (Wynn, 2008). Formation of fibrous tissue
occurs when myofibroblasts generate and deposit extracellular matrix (ECM) components such
as collagen and fibronectin at the site of injury. In normal wound healing, inflammation as well
as the deposition of ECM should cease after tissue damage has been resolved. Chronic
inflammation and accumulation of ECM components could lead to prolonged activation of
wound repair processes that could further exacerbate damaged tissues. Consequently, this
dysregulation could result in permanent fibrotic scarring known as fibrosis (Distler et al., 2019).
There are several causes of fibrosis at the ocular surface that could lead to severe visual
impairment. For example, fibrosis of the cornea can occur due to viral infections, dysfunctional
metabolic processes, or physical trauma or chemical contact to the eye. Conjunctival fibrosis
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could arise following immune-mediated conditions including ocular mucous membrane
pemphigoid, Stevens-Johnson syndrome, and graft-versus-host disease (Mallone et al., 2021).
ii. Graft-Versus-Host Disease (GVHD)
Globally, more than 30,000 patients each year undergo allogeneic hematopoietic stem
cell transplantation (HSCT) in order to treat life-threatening malignancies including leukemia,
lymphoma, sickle cell anemia, and immunodeficiency diseases (Hill et al., 2021). Graft-versushost disease (GVHD) is a severe complication of allogeneic HSCT. GVHD is an autoimmune
condition in which donor marrow (graft) attacks the recipient’s (host) tissues as foreign. Prior to
receiving a bone marrow transplant, patients undergo either total body irradiation or
chemotherapy to ablate their marrow (Gehlsen et al., 2021). HLA mismatch between the donor
and the recipient, female donor to male recipient, patient age, and intensity of conditioning
regimen such as irradiation are a few of the risk factors that have been consistently reported for
GVHD (Flowers et al., 2011). There are two forms of GVHD: acute and chronic. The clinical
manifestations of acute GVHD primarily occur in the skin, liver, and the gastrointestinal tract.
Chronic GVHD impacts the skin and the mucosal surfaces including those found in the mouth,
lungs, gastrointestinal tract as well as the eyes (Ferrara et al., 2009).
iii. Ocular GVHD-Associated Fibrosis
Ocular involvement has been reported in patients suffering from acute or chronic GVHD.
More than 40% of patients who have undergone allogeneic HSCT develop ocular GVHD
(oGVHD). Moreover, oGVHD is mainly associated with chronic GVHD and develops in 4060% of patient cases (Nassiri et al. 2013). In acute oGVHD, the clinical manifestations
commonly include conjunctivitis, photophobia, corneal epithelial keratitis, corneal ulceration,
and lagophthalmos. Chronic oGVHD is primarily characterized by severe ocular damage due to
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fibrotic changes in the ocular surface and especially to the ocular mucosa. The clinical
manifestations of chronic oGVHD include dry eye, keratoconjunctivitis sicca, keratinization,
epithelial thinning, and meibomian gland atrophy (Nassar et al., 2013; Nair et al., 2021).
The ocular surface includes the cornea, conjunctiva, and lacrimal glands (Figure 1). The
conjunctiva is severely affected in oGVHD and the manifestations include conjunctival fibrosis,
symblepharon, and fornix shortening. Clinical reports have shown the presence of fibrotic scars
and damage to the cellular structure and function of the conjunctiva in patients with chronic
GVHD (Kusne et al., 2017; Kheirkhah et al., 2018). Our lab has also previously shown the
presence of conjunctival fibrosis in a mouse model of major MHC-matched and minor MHCmismatched ocular GVHD (Shamloo et al., 2021). In addition to conjunctival fibrosis, fibrosis of
the lacrimal glands has been demonstrated in ocular GVHD (Yamane et al., 2018; Ogawa et al.,
2021).

Figure 1: Diagram showing anatomical parts of ocular surface and tear film.
(American Academy of Ophthalmology; https://www.aao.org/eye-health/anatomy/parts-of-eye)

Macrophage Biology
i. Macrophage Origins
The ocular surface is endowed with heterogenous populations of innate immune cells
including macrophages, dendritic cells, neutrophils, mast cells, natural killer cells, and
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Langerhans cells. Macrophages are sentinel phagocytic cells of the innate immune system. These
large cells protect the host against microbes and clear dead and senescent cells as well as debris
by phagocytosis. They also act as antigen-presenting cells, thus playing a role in both innate and
adaptive immunity (Iwasaki and Medzhitov, 2015).
Based on their hematopoietic origin, there are two main macrophage populations: tissueresident and bone marrow-derived (Figure 2). Recent studies have identified that tissue-resident
macrophages primarily derive from the yolk sac during embryogenesis and populate into the
tissues prior to birth (Davies and Taylor, 2015). Moreover, there are two subpopulations of yolksac derived tissue-resident macrophages: erythromyeloid progenitor cell-derived and fetal liver
precursor cell-derived. These yolk sac-origin erythroid and liver precursor cell-derived
macrophages represent long-lived tissue resident populations. These macrophages undergo local
self-renewal and self-proliferation after birth (Liu and Li, 2021). After establishing residence in
the tissues, these macrophages can maintain their presence into adulthood independently of
contributions from bone marrow-derived precursors. Finally, tissue-resident macrophages
perform the characteristic localized clearance by phagocytosis and immune regulation (Ginhoux
and Guilliams, 2016). The second set of macrophage population originates from monocytes
derived from hematopoietic stem cells (Lu et al., 2020). These monocyte-derived macrophages
represent bone marrow-derived populations that circulate in the bloodstream and undergo
chemotaxis to enter the tissues during immune response. These infiltrating macrophages perform
the characteristic inflammatory response to invading pathogens as well as tissue repair and
inflammation resolution. Upon depletion, these bone marrow-derived macrophages are
replenished by circulating monocytes (Bailey et al., 2020; Liu and Li, 2021).
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Figure 2: Origin of Tissue-Resident and Bone Marrow-Derived Macrophages.
(Thermo Fisher Scientific: https://www.thermofisher.com/us/en/home/life-science/cell-analysis/cell-analysislearning-center/immunology-at-work/macrophage-cell-overview.html)

ii. Macrophage Activation & Polarization
a) Macrophage Phenotypes: Inflammatory & Profibrotic
In addition to hematopoietic diversity, macrophages are heterogeneous cells that display a
spectrum of plasticity in response to a variety of stimuli (Figure 3). These macrophage
phenotypes are prominently involved in initiating and resolving inflammation as well as tissue
restoration. Based on their phenotypic plasticity, macrophages can be classified into two main
functional phenotypes: M1 classically-activated pro-inflammatory and M2 alternativelyactivated anti-inflammatory or profibrotic (Funes et al., 2018).

Figure 3: Macrophage Plasticity.
Macrophages display a diverse spectrum of plasticity and can polarize into two main phenotypes: M1 classicallyactivated and M2 alternative-activated. (Chambers et al., 2021)
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Non-activated M0 macrophages can differentiate into the M1 phenotype in response to
pro-inflammatory stimulation such as IFN-g and TNF-a, pathogen-associated molecular patterns
including lipopolysaccharide (LPS), growth factors including GM-CSF, and endogenous noxious
signals. M1 macrophages are CD80+CD86+ that promote acute and chronic inflammation by
expressing inflammatory mediators including inducible nitric oxide synthase (iNOS), reactive
oxygen species, IL-1b, IL-6, TNF-a, CCL2, and COX2. M1 macrophages induce an increase in
nitric oxide production through iNOS activity, which promotes the characteristic inflammatory
response during cell-mediated immune reactions (Klopfleisch, 2016). M1 macrophages possess
enhanced cytotoxic mechanisms, microbicidal and tumoricidal capabilities, and anti-proliferative
effects that are important components of host defense against invading pathogens (Mosser and
Edwards, 2008). However, unresolved inflammation may exacerbate tissue injury especially by
damaging neighboring tissue, which can further impede the wound healing process (Figure 4).
In contrast, M0 macrophages can differentiate into the M2 phenotype in response to
stimulation by IL-4 and IL-13, immune complexes, adenosine, and glucocorticoids. M2
macrophages can be further classified as M2a, M2b, M2c, and M2d (Figure 3). Particularly, M2a
macrophages are CD163+CD206+ that can attenuate inflammatory responses by expressing antiinflammatory and profibrotic mediators including arginase-1, IL-10, and TGF-b. M2
macrophages can also express angiogenesis mediators such as vascular endothelial growth
factors (VEGFs) and epidermal growth factors (EGFs). The M2 phenotype can oppose M1 proinflammatory activity to promote tissue regeneration (Figure 4). M2 macrophages show higher
levels of urea and ornithine production through arginase-1 activity, further leading to promoting
the production of ECM components such as collagen during wound healing (Klopfleisch, 2016;
Funes et al., 2018). However, M2 macrophages have also been associated with uncontrolled
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activation of fibrotic pathways and pathological tissue remodeling due to overproduction of
extracellular matrix that is characteristic of fibrosis (Mosser and Edwards, 2008).

Figure 4: Macrophage Phenotypes having Pro-inflammatory and Anti-inflammatory Functions to initiate and
resolve inflammation, respectively. (Funes et al., 2018)

b) Transcriptional Mechanisms Underlying Macrophage Polarization
There are several regulatory pathways that impact macrophage polarization (Figure 5).
IFN-g is one of the major stimuli that activates transcription factor STAT1. LPS stimulation
leads to activation of toll-like receptor 4, which further activates nuclear factor kappa B (NFkB). These key transcription factors together help drive non-activated macrophages to
preferentially polarize into the M1 classically-activated phenotype that exhibits the characteristic
pro-inflammatory and cytotoxic profile (Murray et al., 2014; Wang et al., 2014).
In contrast, macrophages can also be preferentially driven toward the M2 antiinflammatory phenotype by stimulation with cytokines such as IL-4, IL-13, and IL-10.
Stimulation by IL-4 and IL-13 leads to the activation of transcription factor STAT6, while IL-10
stimulation activates STAT3. Together these factors can direct macrophages to polarize into the
M2 phenotype associated with inflammatory resolution and wound healing processes (Murray et
al., 2014; Wang et al., 2014).
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Figure 5: Stimuli and Transcription Factors Mediating Macrophage Polarization. (Thermo Fisher Scientific:
https://www.thermofisher.com/us/en/home/life-science/cell-analysis/cell-analysis-learning-center/immunology-atwork/macrophage-cell-overview.html)

c) Metabolic Mechanisms Underlying Macrophage Polarization
One of the most critical metabolic pathways that regulates macrophage phenotype is
arginine metabolism (Figure 6). Although classified as a non-essential amino acid, arginine plays
a role in regulating both innate and adaptive immunity. The major enzymes that compete for
arginine metabolism are nitric oxide synthase (NOS) and arginase, where metabolic activity is
dictated by the presence of pro- and anti-inflammatory cytokines (Yang and Ming, 2014;
Rodriguez et al., 2017). Pro-inflammatory stimulation can activate transcription factors NF-kB
and STAT1, leading to classically-activated M1 macrophages that express inducible nitric oxide
synthase (iNOS). In contrast, stimulation by anti-inflammatory cytokines leads to activation of
STAT3 and STAT6, resulting in alternatively-activated M2 macrophages that express arginase-1
(Murray et. al, 2014).
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Figure 6: Arginine Metabolism and Polarization of Macrophages. (Yang and Ming, 2014).

Inducible NOS (known as NOS2) is regulated by pro-inflammatory cytokines including
IFN-g, TNF-a, and IL-1b as well as bacterial LPS. Upon stimulation, iNOS metabolizes arginine
to ultimately produce nitric oxide (NO) and citrulline, which promote cytotoxic reactions and the
characteristic killing mechanisms by classically-activated macrophages (Rodriguez et al., 2017).
NO production by M1 macrophages also leads to reduced cell proliferation. Therefore,
production of significant quantities of NO is critical for innate immunity, where iNOS acts as an
important mediator during inflammation and defense against invading pathogens (Gerber et al.,
2019). However, overexpression of iNOS can lead to dysregulated production of NO, resulting in
toxic effects and tissue damage implicated in diseases associated with chronic inflammation,
sepsis, diabetes, and cancer (Cinelli et al., 2020).
Arginase-1 (Arg-1) is regulated by anti-inflammatory cytokines such as IL-4 and IL-13.
Arg-1 metabolizes arginine to produce ornithine as the precursor for polyamines and proline,
which promote cell proliferation and wound healing processes, respectively, associated with the
M2 macrophage phenotype. Production of ornithine ultimately contributes to the production of
extracellular matrix, which is a critical component of the wound healing process. Arg-1 also
metabolizes arginine to produce urea, which plays a major role in detoxification of amino acid
metabolism and protein degradation by reducing nitrogen levels from the body. Arg-1 acts as an
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anti-inflammatory mediator by limiting the local availability of arginine, leading to reduced
nitric oxide levels and iNOS activity. Thus, directing arginine metabolism toward Arg-1 activity
is critical in resolving inflammation and promoting tissue repair (Yang and Ming, 2014;
Rodriguez et al., 2017). However, M2 macrophages have also been shown to induce tissue
fibrosis. In recent years, the M2 phenotype has been also linked to possessing tumorigenic
characteristics, where immunosuppressive tumor-associated macrophages have been shown to
express Arg-1 (Arlauckas et al., 2018).
Ocular Surface Macrophages and Their Physiological Functions
Due to its surface location, the ocular surface can be inflicted by potential abrasion as
well as encounter harmful agents such as toxic substances and microbes. Consequently, the
ocular surface possesses a unique innate immune system to protect it. Macrophages are present
in both major components of ocular tissues i.e., the conjunctiva and the cornea. As in other
tissues, ocular surface macrophages perform their characteristic functions essential for host
defense and homeostasis including phagocytosis, initiating and resolving inflammation, tissue
repair, and antigen presentation (Akpek and Gottsch, 2003; Hadrian et al., 2021). For example,
macrophages in the subepithelial tissue of the conjunctiva are one of the primary cells that exert
an initial acute immune response against invading pathogens (Bauer et al., 2002). In addition,
studies have identified two main corneal macrophage populations using macrophage marker
CD64. These populations can be categorized as CD64+CCR2+ and CD64+CCR2- macrophages.
CD64+CCR2+ corneal macrophages are mainly replenished by circulating monocytes, whereas
CD64+CCR2- corneal macrophages have been noted to perform local self-maintenance and selfproliferation. Studies have also shown that CD64+CCR2+ corneal macrophages express classical
pro-inflammatory genes, such as IL-1b and TNF-a, characteristic of the M1 phenotype to
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promote an inflammatory response upon corneal injury. In contrast, CD64+CCR2- corneal
macrophages express anti-inflammatory genes, such as IL-10 and Arg-1, characteristic of the M2
alternatively-activated phenotype that resolve inflammation. CD64+CCR2- corneal macrophages
have also shown to contribute to the morphological features of the cornea and play a critical role
in corneal wound repair. Overall, these two corneal macrophage populations play a crucial role
during corneal wound healing. Dysregulation of these macrophages could lead to severe
impairment of the corneal wound healing, compromise of corneal transparency and ultimately
vision (Liu and Li, 2021).
Macrophage-Mediated Profibrotic Pathways
Macrophages play a key role in promoting profibrotic signaling pathways involving the
activation of fibroblasts. A variety of profibrotic cytokines and mediators released by
macrophages can affect fibroblast transdifferentiation into myofibroblasts (Figure 7). These
profibrotic mediators include transforming growth factor-b (TGF-b), components of the reninangiotensin system (RAS), macrophage colony-stimulating factor (M-CSF), and platelet-derived
growth factor (PDGF). Particularly, it has been demonstrated that alternatively-activated M2
macrophages are involved with wound healing as well as tissue fibrosis. Fibrosis studies in a
variety of tissues such as the kidneys, lungs, and heart have shown that the M2 phenotype
promotes the progressive deposition of ECM and tissue scarring by secreting significant
quantities of profibrotic mediators that affect fibroblast activation and transdifferentiation (Wynn
and Vannella, 2016; Wang et al., 2021).
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Figure 7: Schematic Diagram of Various Fibrotic Signaling Pathways. (Wang et al., 2021)

i. Transforming Growth Factor-b1 (TGF-b1)
The TGF-b superfamily consists of potent, pleiotropic cytokines that play critical roles in
tissue homeostasis, angiogenesis, wound healing, immunoregulation, and apoptosis. There are
three known isoforms of TGF-b that are identified as TGF-b1, 2, and 3, where all three isoforms
are expressed in fibrotic tissues. However, tissue fibrosis is prominently associated with TGF-b1.
Signaling for members of the TGF-b family consists of two major pathways: Smad-dependent
(canonical signaling) and Smad-independent (non-canonical signaling). Moreover, studies have
suggested that the canonical ALK5/Smad3 pathway largely contributes to the pathogenesis of
fibrosis in various tissues (Biernacka et al., 2011). While TGF-bs are essential for the growth and
differentiation of various cells including fibroblasts and myofibroblasts, it has been widely
studied in renal, cardiac, and ocular tissues that excessive secretion of TGF-b1 is highly
implicated in fibrogenesis (Gupta et al., 2020; Wang et al., 2021). One of the most important
functions of TGF-b is the upregulation of ECM components during wound repair, including
collagens, proteoglycans, and glycoproteins. TGF-b also inhibits metalloproteinase activity,
thereby enhancing ECM production (Isaka, 2018). Excessive secretion of TGF-b leads to
significant fibrotic changes and increased levels of a-smooth muscle actin (a-SMA), which is a
17

myofibroblast biomarker of fibrosis (Figure 8). In addition, uncontrolled TGF-b signaling could
result in overproduction of ECM components by fibroblasts that contribute to the progressive
formation of scar tissue (Ueshima et al., 2019).

Figure 8: Macrophages, TGF-b and Fibrosis. (Wynn and Vannella, 2016)

ii. Wnt/b-Catenin Signaling Pathway
Wnt/b-catenin signaling is a conserved pathway. The Wnt ligand family consists of a variety
of secreted glycolipoproteins essential for cell proliferation, cell polarity, embryonic
development, and tissue homeostasis. Canonical Wnt signaling involves the regulation of
transcriptional co-activator b-catenin, where stabilization of cytosolic b-catenin activity is
critical for Wnt signaling transduction, intercellular adhesion, and developmental processes
(MacDonald et al., 2009). Mutations in the Wnt pathway have been associated with birth defects,
hereditary disorders, and cancer. In renal studies, the Wnt/b-catenin signaling pathway is
activated in several kidney diseases. While the Wnt/b-catenin pathway promotes tissue repair
during acute kidney injury, prolonged and dysregulated activation may lead to fibrosis.
Macrophages are sources of Wnt components that can direct tissue repair. In parallel, Wnt
components can promote macrophage proliferation and activation, which could contribute to a
cycle of activation of fibrotic pathways. Studies in other tissues have also demonstrated
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macrophage involvement in inducing the expression of components of the Wnt/b-catenin
pathway that are implicated in fibrogenesis (Wang et al., 2021).
iii. Renin-Angiotensin System
The renin-angiotensin system (RAS) is best known for its critical role in regulating blood
volume, blood pressure, and sodium homeostasis. However, activation of components of RAS
have been shown to contribute to the pathogenesis of several conditions including hypertension,
cardiac diseases, and fibrosis. RAS consists of two pathways: classical and alternative. In the
classical pathway, renin converts angiotensinogen into angiotensin I, which further converts into
angiotensin II by angiotensin-converting enzyme (ACE). It is noteworthy that the classical
pathway is involved with potentiating profibrotic signaling. In contrast, the alternative pathway
reduces the activity of the classical pathway by promoting anti-inflammatory and anti-fibrotic
mechanisms. In addition to the heart, activation of RAS has been consistently demonstrated in
fibrosis of other tissue such as the skin, liver, and kidneys after a diverse array of injury (Kong et
al., 2014; AlQudah et al., 2020). Our lab has also demonstrated for the first time that RAS
activation plays a role in GVHD-associated conjunctival fibrosis, where there was a significant
increase in the gene expression of angiotensinogen and ACE in the conjunctival tissue of mice
with GVHD (Shamloo et al., 2021).
iv. Macrophage Colony-Stimulating Factor (M-CSF)
M-CSF is a potent cytokine that regulates and simulates the proliferation, differentiation,
and activation of monocytes and macrophages. While macrophages are sources of M-CSF, this
signaling has been found to potentiate fibrotic pathways. A pulmonary fibrosis study has
demonstrated that inhibition of M-CSF/M-CSFR signaling led to selective loss of monocytederived alveolar macrophages. Moreover, depletion of these macrophages had resulted in
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reducing the severity of fibrosis in the lungs (Joshi et al., 2020). It is worthwhile to mention that
fibroblasts can also modulate macrophage biology through the secretion of M-CSF. Therefore,
fibrosis is associated with elevated levels of M-CSF, which could result in further proliferation
and activation of macrophages and setting up a vicious cycle of fibrosis (Borrello and Phipps,
1999).
v. Platelet-Derived Growth Factor (PDGF) & Connective Tissue Growth Factor (CTGF)
Platelet-derived growth factor is one of the initial growth factors deposited in damaged
tissues by degranulating platelets. PDGF is essential for fibroblast proliferation and migration
into the site of injury. In addition, increased levels of PDGF may lead to enhanced fibroblast
activity as well as indirectly increasing ECM synthesis and wound tensile strength. However,
uncontrolled PDGF signaling in injured connective tissue has been implicated in fibrotic
disorders such as systemic sclerosis and dermal scarring (Rajkumar et al., 2006). Macrophages
can be sources of PDGFs, where these growth factors serve as chemotactic agents for
myofibroblasts and promote myofibroblast proliferation and production of ECM components
such as collagen and fibronectin (Chegini, 2010). Another profibrotic mediator produced by
macrophages is connective tissue growth factor, which is one of the key regulators of cell
proliferation, angiogenesis, and connective tissue repair mechanisms and wound healing. While
CTGF is critical for embryonic development and the physiological function of various organs,
overexpression of CTGF has been implicated in several adulthood diseases including tissue
fibrosis (Chen et al., 2020).
vi. Other Profibrotic Mediators
Epidermal growth factors such as EGF, TGF-a, and heparin-binding EGF act as mitogenic
factors and regulate differentiation of a variety of cells including fibroblasts. Expression of EGFs
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plays a role in wound repair processes. However, these growth factors have also been indicated
in tissue fibrosis and could promote fibroblasts and myofibroblasts to overproduce extracellular
matrix. EGFs may also interact with other growth factors such as PDGFs that could contribute to
the progression of fibrosis. Insulin-like growth factors (IGFs) are involved in growth and
metabolism. IGFs in tandem with EGFs and PDGFs can induce fibroblast proliferation that could
further give rise to fibrogenesis. VEGFs and fibroblast growth factors play important roles in
angiogenesis and wound healing by stimulating the proliferation and activation of fibroblasts.
However, these factors can also be involved in the pathogenesis of tissue fibrosis (Chegini,
2010).
Effects of Radiation on Macrophage Activation
Radiation therapy remains as one of the widely used treatment options for life-threatening
conditions including many cancers. For bone marrow transplant, patients must undergo a
conditioning regimen such as total body irradiation to ablate their diseased bone marrow.
Although irradiation impacts the biological function and viability of immune cells, studies have
indicated that radiation exposure may induce macrophage activation status. For example,
ionizing radiation has been reported to affect macrophage activation by modulating the
expression of classical and alternative macrophage markers (Wu et al., 2017). A variable trend of
pro-inflammatory markers, such as CCL2, IL-6, and CD80, have been observed upon radiation
exposure. Studies have also shown a variable trend in the expression of anti-inflammatory
markers including CD163, CD206, and IL-10 (Teresa Pinto et al., 2016; Mikhalkevich et al.,
2021).
Macrophages exhibit resistance to the effects of ionizing radiation. Although DNA
damage can be induced by irradiation in macrophages, apoptosis may or may not occur
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depending on the level of exposure. It has been shown that macrophages are viable and
metabolically active even after radiation exposure of 10 Gy, suggesting that irradiation does not
significantly induce apoptosis (Teresa Pinto et al., 2016). Moreover, it is also worthy to note that
M2 anti-inflammatory macrophages have been shown to be more radioresistant in comparison to
M0 and M1 pro-inflammatory macrophages (Leblond et al., 2017).
Macrophage-Fibroblast Cross-Talk in Ocular GVHD-Associated Fibrosis
The outermost layer of the ocular surface is composed of corneal epithelium and
palpebral and bulbar conjunctiva that represent features of connective tissue and the mucosa. The
ocular surface contains resident macrophages and fibroblasts (Palomar et al., 2019; Alfuraih et
al., 2020). Insults on the ocular surface such as mechanical injury or radiation could lead to the
activation of macrophages and release of profibrotic mediators that could induce the
transdifferentiation of fibroblasts into myofibroblasts. Consequently, this unregulated activation
could result in ocular surface fibrosis. The underlying mechanisms of ocular surface fibrosis in
the context of GVHD are still being understood. Currently, there are no studies that have
investigated the effect of radiation on macrophage activation and how it affects the crosstalk
between macrophages and fibroblasts in the context of GVHD-associated ocular surface fibrosis.
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Murine Macrophage Culture & Polarization
To obtain murine macrophages, hematopoietic stem cells from the bone marrow of
femurs and tibias isolated from BALB/c mice. The mice were euthanized using CO2 and marrow
was flushed out using 1X solution of Ca2+/Mg2+-free PBS with 2% FBS. Red blood cells were
lysed by incubating with a commercially available lysis buffer for 3 minutes (BD Biosciences,
Frankline Lakes, NJ, USA). The cells were centrifuged at 1500 rpm for 5 minutes and
resuspended in 18 ml of macrophage growth medium (Table 1). The cells were plated in three 6well plates (USA Scientific, Inc, Ocala, FL, USA) and cultured in macrophage medium
containing M-CSF at 37°C with 5% CO2 and 95% humidity in a cell culture incubator (Forma
series II water jacket, Thermo Fisher Scientific, Marietta, OH, USA). The media was replaced
three times during a 7-day period to obtain M0 macrophages. The M0 macrophages thus
obtained were further polarized into M1 and M2 macrophages (Ying et al., 2013).
M1 macrophage polarization was initiated by culturing the M0 macrophages in medium
supplemented with IFN-g + LPS (Table 2). These cells were exposed to M1 macrophage medium
for 48 hours. M2 macrophage polarization was initiated by culturing the M0 macrophages in
medium supplemented with IL-4 (Table 3). These cells were exposed to M2 macrophage
medium for 72 hours. Representative images of the polarized macrophages were obtained using
EVOS microscope (Thermo Fisher Scientific, Marietta, OH, USA). The macrophages were
stained for M0, M1, and M2 markers (Table 4) and analyzed using flow cytometry to confirm
polarization (FACSVerse Flow Cytometer, BD Biosciences, Franklin Lakes, NJ, USA). Realtime PCR was used to quantify gene expression of M1 and M2 markers iNOS and arginase-1,
respectively. Real-time PCR and antibody-coated bead-mediated flow cytometry protein
quantification were used to quantify macrophage chemokines CCL17 and CCL22.
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Table 1: Composition of Macrophage Growth Medium
Components
Iscove’s Modified Dulbecco’s Medium
Heat-Inactivated Fetal Bovine Serum
Penicillin/Streptomycin
M-CSF

Concentration
10%
100 U/mL
10 ng/µL

Table 2: Composition of M1 Macrophage Medium
Components
Macrophage Growth Medium
IFN-g
LPS

Concentration
50 ng/µL
100 ng/mL

Table 3: Composition of M2 Macrophage Medium
Components
Macrophage Growth Medium
IL-4

Concentration
20 ng/µL

Table 4: Macrophage Markers
Macrophage
Phenotype
M0
M0
M1
M2

Anti-Mouse
Marker
CD11b
F4/80
CD86
CD206

Fluorochrome

Detection

Alexa 647
BV510
APC/Cy7
PE

Red (633 nm)
Violet (405 nm)
Red (633 nm)
Blue (488 nm)

Murine Corneal Fibroblast Culture
To test the effect of macrophage polarization on fibroblast transdifferentiation, murine
corneal fibroblasts were used (Mittal et al., 2016; Lin et al., 2007). These murine corneal
fibroblasts are human telomerase reverse transcriptase (hTERT) immortalized cells and do not
show any sign of senescence until 100 passages. These murine fibroblasts are termed as MK/T-1
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cells (Gendron et al., 2001). The cells were plated at a density of 1 x 106 cells/mL in a T-25 flask
(CytoOne® USA Scientific, Inc, Ocala, FL, USA). The cells were cultured in fibroblast growth
medium containing 2% FBS at 37°C with 5% CO2 and 95% humidity (Table 5). The cells were
maintained until at least 80% confluence was reached. The cells were then trypsinized and plated
in 12-well inserts (SABEU GmbH & Co. KG, Northeim, Germany) for a 12-well plate
(CytoOne® USA Scientific, Inc, Ocala, FL, USA) at a density of 1x104 cells/mL. For
immunostaining experiments, the cells were plated in tissue cultured treated 4-chambered glass
slides (Corning Inc., Big Flats, NY, USA) at a density of 8 x 104 cells/mL. The corneal
fibroblasts were co-cultured in inserts placed on top of M0, M1, and M2 macrophages.
Table 5: Composition of Fibroblast Growth Medium
Components
Dulbecco’s Modified Eagle Medium
L-Glutamine
Heat-Inactivated Fetal Bovine Serum
Penicillin/Streptomycin
Sodium Pyruvate

Concentration
200 mM
2%
100 U/mL
100 mM

Macrophage Polarization and Fibroblast Transdifferentiation
To test the effect of macrophage polarization on fibroblast differentiation, ocular surface
fibroblasts were cultured on clear 0.4 µm PET-membrane cell culture inserts (SABEU GmbH &
Co. KG, Northeim, Germany). The inserts were then placed in 6 or 12 well plates containing
cultures of M0, M1 or M2 macrophages on the bottom well of these plates as shown below in
Table 6. The fibroblasts and macrophages were co-cultured for 3 days. The experiments were
conducted in duplicate. Immunostaining and gene expression quantification for a-SMA was used
as a marker for myofibroblast formation.

26

Table 6: Experimental Design of Fibroblast Treatment

Inserts
Bottom
Wells

Fibroblasts
Media only

Treatment
Fibroblasts
Fibroblasts
M0
M1
macrophages macrophages

Fibroblasts
M2
macrophages

a-SMA Immunostaining

The cells were rinsed with 1x PBS and fixed in 4% paraformaldehyde for 15 minutes
followed by rinsing with 1x PBS. The cell membranes were permeabilized with a 1x PBS
solution containing 0.25% Tween20 for 15 minutes. The cells were rinsed again with 1x PBS
and non-specific binding was blocked with a 1x PBS solution containing 2% BSA for 30
minutes. The cells were incubated with the murine primary antibody for a-SMA at a dilution of
1:100 for 90 minutes (Invitrogen, Waltham, MA, USA). The cells were washed with 1x PBS and
then incubated with Alexa Fluor 488 goat anti-mouse secondary antibody at a dilution of 1:250
for 60 minutes (Invitrogen, Waltham, MA, USA). The nuclei were stained with DAPI. The
immunostained cells were imaged using confocal microscopy (Nikon, Melville, NY, USA).
Image J Software (National Institutes of Health, MD, USA) was used to quantify the number of
nuclei stained for a-SMA.
Isolation of mRNA and Preparation of cDNA
To test the effect of polarized macrophages on the expression of profibrotic gene in the
ocular surface fibroblasts, RNA was isolated, reversed transcribed to cDNA and gene expression
was quantified using real-time PCR.
A commercially available kit (QIAGEN’s RNeasy Mini Kit) was used to isolate the
mRNA. The media was aspirated from each well and 350 µL of RNase inhibitor containing RLT
buffer was added to each well to induce cell lysis. The lysate was then transferred to the QIA
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shredder spin column and centrifuged to further facilitate shredding. The flow-through was
collected and an equal volume of 70% molecular biology grade ethanol was added to the lysate
to precipitate the DNA. The lysate was transferred to the RNeasy spin column which binds RNA.
The column was centrifuged at 10,000 rpm for 30 seconds. The column was then washed with
RW1 buffer and RPE buffer. Finally, 30 µL of RNase-free water was added to the column
membrane and incubated for 5 minutes at room temperature followed by centrifugation for 1
minute to elute the RNA. The isolated RNA was immediately used for cDNA synthesis.
The RNA was reversed transcribed to cDNA using a commercially available kit
(SuperScript® III First-Strand, Invitrogen, CA, USA). For each RNA sample, 8 µL of isolated
RNA sample was combined with 1 µL of 50 µM oligo(dT)20 primer and 1 µL of 10 mM dNTP
mix. The mixture was incubated at 65°C for 5 minutes using MiniAmp Thermocycler followed
by incubation on ice for 1 minute (Applied Biosystems, Thermo Fisher Scientific, Singapore). A
10 µL of cDNA synthesis mixture was added to the reaction mixture containing the RNA sample
(Table 7). The mixture was incubated at 50°C for 50 minutes followed by 85°C for 5 minutes.
The samples were incubated on ice for 1 minute followed by the addition of 1 µL of RNase H.
The mixture was incubated at 37°C for 20 minutes. Lastly, 40 µL of DEPC water was added to
the reaction mixture to complete cDNA synthesis.
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Table 7: Composition of cDNA Synthesis Mixture
Components
10X RT Buffer
25 mM MgCl2
0.1 M DTT
RNaseOut™ (40 U/ µL)
Superscript III RT (200 U/ µL)

1 Sample
2 µL
4 µL
2 µL
1 µL
1 µL

Real-Time PCR
The gene expression of the following genes was quantified using real-time PCR: a-SMA,
TGF-β1, angiotensinogen, ACE, M-CSF, and PDGF. For each gene, a PCR master mixture
containing SYBR green PCR master mix (Applied Biosystems, Thermo Fisher Scientific,
Waltham, MA) was prepared as shown in Table 8 and using the primers shown in Table 9. A
total of 20 µL was used per reaction (2 µL cDNA + 18 µL master mix). Beta actin was used as
the housekeeping gene. QuantStudioTM 3 Real-Time Thermocycler was used to run the PCR
reactions (Applied biosystems, Thermo Fisher Scientific, Singapore). The thermocycler settings
for PCR: a) Step 1 (Activation): 50°C for 2 minutes then 95°C for 2 minutes for thermal
activation of AmpliTaq Gold DNA Polymerase; b) Step 2 (PCR): 40 cycles of 95°C for 15
seconds to cause denaturation and 60°C for 1 minute for annealing and extension; c) Step 3
(Melt Curve): 95°C for 15 seconds, 60°C for 1 minute, and then 95°C for 15 seconds.
Table 8: Composition of Real-Time PCR Master Mix
COMPONENTS
Master Mix (SYBR Green)
F primer for target gene
R primer for target gene
DEPC water
Total Volume
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VOLUME
PER REACTION
10 µl
2 µl
2 µl
4 µl
18 µl

Table 9: List of Murine Genes and Forward and Reverse Primers
GENE
α-SMA
TGF-βR1
Angiotensinogen
ACE
M-CSF
PDGF
CD80
iNOS
CCL2
IL-1b
TNF-a
IL-6
CD206
Arginase-1
IL-10
CCL17
CCL22
β-Actin

FORWARD
PRIMER

REVERSE
PRIMER

CGA TCA TGC GTC TGG ACT T

GGC AGT AGT CAC GAA GGA ATA

GGG CTT AGT GTT CTG GGA AA

CCG ATG GAT CAG AAG GTA CAA G

TCC CAG GCT CTC TGG ATT TA

CAA GTT CAT CTT CCA CCC TGT

GAC AGG TTC GTG GAA GAG TAT

TTG CTG CCC TCT ATG GTA ATG

GAC AGA TGA GAA GGA GCA GAA G

GCT GTC CCA CCC TTT GAA TA

GTC CAT ACG GGA AGA GCT AAA G

GGA GAC AAC AGG CAC AAT TTC

TCG GCG CAG TAA TAA CAG TC

GTT TCT CTG CTT GCC TCA TTT C

GCC TGT GAG ACC TTT GAT GT

TGG ATG AGC CTA TAT TGC TGT G

GAA GGA ATG GGT CCA GAC ATA C

CAC ATT CAA AGG TGC TGA AGA C

CCA CCT CAA TGG ACA GAA TAT CA

CCC AAG GCC ACA GGT ATT T

TTG CTC TGT GAA GGG AAT GG

GGC TCT GAG GAG TAG ACA ATA AAG

TTT CCT CTG GTC TTC TGG AGT A

CTC TGA AGG ACT CTG GCT TTG

CAG GTG GCT TAT GGG ATG TT

CAT TTG GGT TCA GGA GTT GTT G

GGG CTC CTT TCA GGA CTA GAT A

CGA AGC AAG CCA AGG TTA AAG

TTG AAT TCC CTG GGT GAG AAG

TCC ACT GCC TTG CTC TTA TTT

GGA AGT TGG TGA GCT GGT ATA A

GAT GGC CTT CTT CAC ATG TTT G

ACA CAC CTC CCA AGT TTC TAT C

CAG CCT GAA ACT CCC AGA AT

CTC CCT GGA GAA GAG CTA TGA

CCA AGA AGG AAG GCT GGA AA

NM ACCESSION
NUMBER
NM_007392.3
NM_009370.3
NM_007428.4
NM_207624.6
NM_007778.4
NM_019971.3
NM_009855.2
NM_001313922.1
NM_011333.3
NM_008361.4
NM_013693.3
NM_031168.2
NM_008625.2
NM_007482.3
NM_010548.2
NM_011332.3
NM_009137.2
NM_007393.5

Effect of Irradiation on Macrophage Activation and Polarization
Bone marrow-derived M0 macrophages were exposed to 7 Gy radiation using an x-ray
irradiator shown in Figure 9 for 3 minutes and 26 seconds (RS 2000 X-ray Biological Irradiator:
Rad Source Technologies, GA, USA). Macrophages were incubated at 37°C with 5% CO2 and
95% humidity to allow for radiation effects.

Figure 9: X-Ray Irradiator. RS 2000 X-ray Biological Irradiator was used to irradiate macrophages. The following
parameters were set: 160 kV, 25.0 mA, Configuration: Shelf Only, Shelf Level: 3, Radiation: 7 Gy, Exposure Time:
3 mins 36 secs.
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Effect of irradiation on macrophage phagocytosis
M0 macrophages were plated at a density of 5 x 104 cells/mL in tissue cultured treated 4chambered glass slides and exposed to irradiation as described above. Two hours after
irradiation, macrophages were exposed to Alexa Fluor™ 594 conjugated zymosan A (S.
cerevisiae) particles (Invitrogen, Waltham, MA, USA) at a dilution of 1:50 and incubated for 15
minutes at 37°C with 5% CO2 and 95% humidity followed by washing twice with 1x PBS. The
cells were fixed with 4% paraformaldehyde for 15 minutes followed by washing with 1x PBS.
The cells were permeabilized using 0.25% Tween20 for 15 minutes followed by washing with 1x
PBS. Non-specific binding was blocked using 2% BSA for 15 minutes. The cell outlines were
visualized by f-actin staining using Alexa Fluor 488 conjugated phalloidin (Invitrogen, Waltham,
MA, USA) at a concentration of 2 drops/mL and incubated for 30 minutes followed by washing
with 1x PBS. The nuclei were stained using DAPI. Phagocytic activity was assessed using
confocal microscopy and the number of macrophages containing zymosan particles were
quantified using Image J Software (Ragsdale and Grasso, 1989).
Effect of irradiation on macrophage apoptosis/necrosis
Six hours after irradiation, macrophages were stained using an Annexin V APC
Conjugated Apoptosis Assay Kit (Cayman Chemical, Ann Arbor, MI, USA). Unstained
macrophages were used as the negative control. A 1x Annexin V binding buffer was prepared
using a cell-based assay Annexin V binding buffer (10x) at a dilution of 1:10 with DI H20. The
cells were trypsinized and collected from 6-well plates followed by centrifugation at 400 x g for
5 minutes. The cells were resuspended in Annexin V APC/DAPI staining solution (Table 10)
using an Annexin V APC assay reagent and DAPI viability dye and incubated in the dark at
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room temperature for 10 minutes. The cells were centrifuged at 400 x g for 5 minutes and
resuspended in 1x PBS. Apoptosis was analyzed using FACS flow cytometry.
Table 10: Composition of Annexin V APC/DAPI Staining Solution
Components
Annexin V APC Assay Reagent
DAPI Viability Dye
1x Annexin V Binding Buffer

Quantity
20 µL
20 µL
2 mL

Effect of irradiation on macrophage activation and polarization
M0 macrophages were plated at a density of 1.6 x 105 cells/well in 6-well plates. Twentyfour hours after irradiation, the mRNA and cDNA were isolated using the methods described
earlier. Real-time PCR was used to quantify the cytokines and markers of classical and
alternative macrophage activation status CD80, iNOS, CCL2, IL-1b, TNF-a, IL-6, CD206, Arg1, and IL-10 using primers listed in Table 9 (Teresa Pinto et al., 2016; Leblond et al., 2017;
Mikhalkevich et al., 2021).
Statistical Analysis
All data are presented as mean ± standard error of the mean. Fold changes of mRNA
were calculated using the DDCt method. Statistical analysis was performed using GraphPad Prism
software (Version 9, San Diego, CA, USA). t test was used for analysis of the data for the
macrophages exposed to irradiation compared to macrophages not exposed to irradiation. One
way ANOVA followed by Tukey’s test was used to perform statistical analysis for comparisons
between M0, M1 and M2 macrophages.
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Polarized Macrophage Culture and Characterization
M0 macrophages were successfully generated from hematopoietic stem cells isolated
from murine bone marrow by culturing them in M-CSF (Figure 10). Flow cytometry data shows
that an average of 70% of these cells expressed Pan macrophage markers CD11b and F4/80 after
culturing them in M-CSF for one week, thus confirming the successful differentiation of M0
macrophages from hematopoietic stem cells (Figure 11). Further polarization of M0
macrophages to M1 and M2 phenotypes was obtained by culturing these cells in M-CSF and
IFN-g + LPS or M-CSF + IL-4, respectively (Figure 10). Flow cytometry data confirmed that an
average of 80% of the macrophages expressed the M1 marker CD86 after culturing them in MCSF and IFN-g + LPS for 48 hours (Figure 11). An average of about 40% of the macrophages
expressed the M2 marker CD206 after culturing them for 72 hours in M-CSF + IL-4 (Figure 11).
Figure 10 shows there is a notable difference in the morphology and confluency of M1
macrophages compared to M0 and M2 macrophages since M1 macrophages undergo significant
levels of apoptosis.

Figure 10: Representative phase contrast microscopy images of cultured and polarized murine
bone marrow-derived macrophages.
We further confirmed the M1 and M2 macrophage phenotypes by gene expression
analysis (Figure 12). In congruence with the flow cytometry data, our gene expression data
confirmed that M1 macrophages expressed high levels of iNOS, a key M1 marker. Similarly, M2
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macrophages showed a very high expression of arginase-1, which is specific for the M2
phenotype (Figure 12).

Figure 11: Flow cytometry data showing the anticipated expression of Pan (CD11b, F4/80), M1
(CD86) and M2 cell surface (CD206) markers confirming the successful generation of
macrophage phenotypes. Full gating scheme for CD11b and F4/80 plots shown in Figure 13.

Figure 12: Real-time PCR quantification showing the anticipated high expression of iNOS genes
in M1 macrophages and arginase-1 genes in M2 macrophages. (The graph shows mean + SEM
data from N = 3 replicates)
Lastly, we confirmed that we were able to successfully identify macrophage phenotypes
in a heterogenous macrophage population. To achieve this goal, we pooled a mixture of M0, M1
and M2 macrophage and characterized them by flow cytometry. Our flow cytometry data shows
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that about 91% of the pooled macrophages expressed CD11b, and 77% of those CD11b+ cells
were also positive for F4/80 (Figure 13). In the mixture, 50% cells were M0
(CD11b+F4/80+CD86-CD206-) and as anticipated based on our mixture of cells, about 17% of
the cells were positive for M1 surface marker CD86, while 23% of the cells were positive for M2
surface marker CD206 (Figure 13). Thus, our data shows that we were able to successfully
characterize M0, M1 and M2 phenotypes in a heterogeneous mixture of macrophages.

Figure 13: Flow cytometry characterization of macrophage phenotypes using Pan (CD11b,
F4/80), M1 (CD86) and M2 cell surface (CD206) markers.
Effect of Irradiation on Macrophage Activation
After generating and charactering M0, M1 and M2 macrophages, we wanted to test the
effect of irradiation on these macrophages. Irradiation is used to ablate diseased bone marrow
prior to the transplantation. Clinical data shows that irradiation is a major risk factor for ocular
GVHD-associated fibrosis. Activated macrophages, especially the M2 phenotype, can release
profibrotic mediators, thus we hypothesized that irradiation-activated generation of M2
macrophages can orchestrate GVHD-associated fibrosis. Therefore, we assessed whether
irradiation causes macrophage activation and polarization. Our data demonstrates that irradiation
caused an increase in gene expression of pro-inflammatory cytokines in M0 macrophages
(Figure 14). After radiation exposure, there was a 2-fold ± 0.29 increase in IL-1b, a 4.2-fold ±
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1.21 increase in TNF-a, and a 2-fold ± 0.99 increase in IL-6. Further, a 2.4-fold ± 0.77 increase
in chemokine CCL2 was also noted (Figure 14). CCL2 is known to cause the recruitment of
monocytes, dendritic cells, and T cells. However, irradiation did not cause any upregulation of
M1 macrophage markers i.e., CD80 and iNOS. In contrast, our data demonstrates that irradiation
caused a robust increase in gene expression of M2 phenotype markers i.e., a 2.7-fold ± 1.5
increase in CD206, a 16.4-fold ± 4.1 increase in arginase-1, and a 4-fold ± 0.4 increase in IL-10
(Figure 14).

Figure 14: Real-time PCR quantification of changes in expression of pro-inflammatory
cytokines, chemokines, M1 and M2 markers twenty-four hours after exposing M0 macrophages
to 7 Gy radiation. (* p< 0.05 compared to control M0 macrophages that were not exposed to
irradiation. The graphs show mean + SEM data from N = 5 replicates)
Effect of Irradiation on Macrophage Phagocytic Activity
Our data demonstrates that exposing M0 macrophages to irradiation caused a notable
increase in the uptake of zymosan particles compared to control macrophages that were not
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exposed to irradiation (Figure 15A). Quantification from 54 images captured at 20X
magnification showed that without irradiation, 41± 2 macrophages engulfed zymosan particles
whereas after irradiation 52±1 macrophages showed engulfed zymosan particles (Figure 15B).
Overall, these results suggest that irradiation potentially promotes macrophage phagocytic
activity.

Figure 15: (A) Representative immunofluorescent confocal microscopy images showing the
effect of irradiation on macrophage phagocytic activity two hours after 7 Gy radiation exposure,
and (B) quantification macrophage zymosan uptake counted from 54 images. (* p < 0.05
compared to control macrophages that were not exposed to irradiation. The graph shows mean
+ SEM data from N= 4 replicates)
Effect of Irradiation on Macrophage Cell Death
Finally, we assessed whether irradiation could cause macrophage cell death. As shown in
Figure 16, our data demonstrates that control macrophages not exposed to irradiation had 85.6±
4.5% viable cells and had 0.22±0.03% necrotic and 14.1±4.5% apoptotic cells. Irradiation did
not alter macrophage viability since irradiated macrophages showed 85.7±3% viability and had
0.11± 0.04% necrotic and 19.8±5.8% apoptotic cells. Therefore, the data suggest that while
irradiation could potentially induce macrophage activation and phagocytic activity, radiation
exposure has no effect on macrophage apoptosis and necrosis and cell viability.
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Figure 16: Representative flow cytometry data assessing macrophage apoptosis/necrosis six
hours after irradiation exposure. The cell population in the lower left quadrant which is not
stained by DAPI and annexin is viable. The cells in the lower right quadrant which are stained
by annexin are apoptotic and cells in upper right quadrant which are DAPI and annexin stained
are necrotic. (The results were mean + SEM data from N= 3 replicates)
Effect of Polarized Macrophages on Ocular Surface Fibroblast Transdifferentiation
Next, we tested whether macrophages could cause transdifferentiation of ocular surface
fibroblasts to myofibroblasts through the release of profibrotic mediators in a paracrine manner.
To test the transdifferentiation of fibroblasts to myofibroblasts, we used a-SMA as a marker for
myofibroblast formation. Our data demonstrates that exposing the fibroblasts to M0 and M2
macrophages was able to induce a noticeable increase in a-SMA expression as shown in Figure
17A. This observation is further supported by the quantification of gene expression of a-SMA,
which shows that both M0 and M2 macrophages were able to induce a significant increase in aSMA gene expression in fibroblasts (Figure 17B). In contrast, M1 macrophages did not induce
a-SMA expression. In summary, our data demonstrates that M0 and M2 macrophages could
potentially induce the transdifferentiation of ocular surface fibroblasts to myofibroblasts.
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Figure 17: (A) Representative immunofluorescent microscopy images and (B) real-time PCR
data showing a-SMA protein and gene expression in cultured corneal fibroblasts that were
exposed to M0, M1 and M2 macrophages. (*p < 0.05 compared to control fibroblasts that were
not exposed to macrophages. The graph shows mean + SEM data from N=4 replicates)
Effect of Polarized Macrophage Exposure on Profibrotic Mediators Expression in Ocular
Surface Fibroblasts
It is already well known that macrophages, especially the M2 phenotype, release a
multitude of profibrotic mediators that can cause transdifferentiation of fibroblasts to
myofibroblasts as was observed in our experiments. We further wanted to test whether these
profibrotic mediators released from macrophages could cause an increase in the expression of
profibrotic mediators in the ocular surface fibroblasts. Our data demonstrates that co-culturing
corneal fibroblasts in inserts on the top of M2 macrophages caused a notable increase in
components of renin angiotensin system i.e., angiotensinogen and angiotensin-converting
enzyme (Figure 18). An increase in TGF-β1 receptor expression was also noted in fibroblasts
upon exposure to both M1 and M2 phenotypes. Lastly, co-culturing corneal fibroblasts in inserts
on the top of macrophages caused a notable decrease in expression of PDGF and no change was
observed in M-CSF gene expression (Figure 18).
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Figure 18: Real-time PCR gene quantification of profibrotic mediators in corneal fibroblasts
exposed to M0, M1, and M2 macrophages. (The graph shows mean + SEM data from N=2
replicates)
Macrophage Phenotypes and T-Helper Attractant Chemokines
Pathological features of ocular GVHD can be divided into three phases and infiltration of
T cells is a key feature towards the end of the first phase extending into the second phase of the
disease pathology. CCL17 and CCL22 are two key chemokines involved in CD4+ T cell
chemotaxis. Thus, we wanted to test whether macrophage polarization results in differential
secretion of these two chemokines. Our data shows that M1 phenotype macrophages have high
gene expression of CCL22 and secrete statistically significantly large quantities of this
chemokine compared to both M0 and M2 phenotypes (Figure 19). M2 macrophages also show a
notably higher expression and secretion of CCL22 compared to M0 phenotypes but not nearly as
high as M1 phenotype. Lastly, both M1 and M2 macrophages secrete CCL17 in notably higher
quantities compared to M0 macrophages (Figure 19).
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Figure 19: Real-time PCR gene quantification and antibody-coated bead-mediated flow
cytometry protein quantification of CCL17 and CCL22 in M0, M1, and M2 macrophages.
(*p<0.05 compared to M0 and M2. The graphs show mean + SEM data from N=3 replicates)
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CHAPTER 5
DISCUSSION
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The ocular surface consists of the cornea and conjunctiva, which contain rich populations
of macrophages and fibroblasts. Damage to the ocular surface can occur due to various noxious
stimuli including mechanical injury, microbial infection, and chronic systemic diseases. As in all
tissues, local response to ocular surface injury involves the initiation of an inflammatory
response by innate immune cells, such as macrophages, followed by wound repair. However,
excessive wound healing can lead to fibrotic alterations to the cornea and conjunctiva, which can
severely impact normal vision (Friedlander, 2007). Damage to the ocular surface has been
implicated in chronic graft-versus-host disease (GVHD), where at least 60% of patients with
GVHD have reported ocular complications following bone marrow transplantation (Herretes et
al., 2015). Moreover, clinical observations have noted that the conjunctiva is significantly
affected by fibrotic scarring in patients with GVHD (Kusne et al., 2017; Kheirkhah et al., 2018).
Innate immunity plays a role in inducing fibrogenesis in ocular GVHD (oGVHD). Our lab has
previously demonstrated that there is a concomitant influx and activation of macrophages
preceding and alongside the onset of fibrosis in the conjunctiva of mice with GVHD (Shamloo et
al., 2021). In addition, studies have demonstrated that M2 phenotype macrophages are involved
in initiating and progressing the pathology of fibrosis by releasing profibrotic mediators (Wang
et al., 2021). However, there are currently no studies that explore whether irradiation prior to
bone marrow transplant induces an effect on macrophage activation and phenotypic plasticity in
the context of ocular GVHD. The present study demonstrates that irradiation can trigger
macrophage activation and polarization, and macrophages can cause the transdifferentiation of
ocular surface fibroblasts to myofibroblasts, thus contributing to ocular surface fibrosis.
In order to study the role of macrophages in ocular surface fibrosis, M0 macrophages
were first obtained by isolating hematopoietic stem cells from murine bone marrow and culturing
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these cells in M-CSF. Macrophages display a spectrum of plasticity in response to a variety of
stimuli and can polarize into two main phenotypes: M1 classically-activated pro-inflammatory
and M2 alternatively-activated anti-inflammatory or profibrotic. Our data demonstrates that we
have successfully obtained the three macrophage phenotypes M0, M1, and M2 using published
methods (Ying et al., 2013) as demonstrated by anticipated expression of Pan, M1 and M2
macrophage markers including CD11b, F4/80, CD86, CD206, iNOS and arginase-1,
(Klopfleisch, 2016; Rodriguez et al., 2017). It is worth noting that our data also demonstrates a
noticeable increase in the expression of the chemoattractants CCL17 and CCL22 in polarized
macrophages, further suggesting that successful macrophage activation was achieved using
published methods.
In addition to biological stimuli, studies have demonstrated that irradiation could induce
macrophage activation and phenotypic changes toward either pro-inflammatory or antiinflammatory (Wu et al., 2017). Several studies have also shown that irradiation as used for
conditioning regimen prior to bone marrow transplantation is a key stimulus to trigger GVHD
including oGVHD (Corvò et al., 1999; Flowers et al., 2011). Moreover, intensity of radiation
dose can affect the severity of oGVHD, wherein injury by irradiation and high autoantigen load
at the ocular surface could potentially activate host tissue-resident macrophages (Perez et al.,
2016). Mikhalkevich et al., 2021 have demonstrated that radiation triggers the expression of proand anti-inflammatory genes in monocytes and macrophages. In line with published literature,
our data also demonstrates that radiation exposure increases the gene expression of proinflammatory cytokines in macrophages and also increases the expression of M2 markers. While
the results indicate that irradiation may trigger the release of pro-inflammatory cytokines from
M0 macrophages, our data suggests that radiation can lead to differentiation toward the M2
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phenotype as shown by the robust increase in gene expression of M2 markers. Our data also
demonstrates that macrophages exhibit increased phagocytic activity and remain largely viable
after radiation exposure, which is complemented by published observations that irradiation does
not affect macrophage metabolic activity and viability (Teresa Pinto et al., 2016). Moreover,
studies have shown that the M2 macrophage phenotype exhibits increased radioresistance and
share many of the characteristic expression patterns as tumor-associated macrophages (Leblond
et al., 2017). Therefore, while radiation-induced injury can also cause macrophage activation,
our data further demonstrates that radiation exposure could direct macrophages toward the M2
phenotype, which could potentially remain viable and initiate and promote aberrant tissue
remodeling in response tissue injury leading to fibrosis as noted in oGVHD (Barker et al., 2015;
Shi and Shiao, 2018).
Clinical studies have shown that patients with oGVHD exhibit features of subtarsal
conjunctival fibrosis and lacrimal gland fibrosis (Ogawa et al., 2010; Kusne et al., 2017;
Kheirkhah et al., 2018). As mentioned, our lab has published data showing the presence of
fibrosis in the palpebral conjunctiva of mice with GVHD. Our lab has also previously
demonstrated that conjunctival fibrosis coincides with an increased influx and activation of
macrophages (Shamloo et al., 2021). Macrophages are sources of a variety of profibrotic
mediators and particularly the M2 phenotype is involved in activating wound healing processes
and present in fibrotic tissues (Arango Duque and Descoteaux, 2014; Braga et al., 2015). As
anticipated, our data demonstrates that M2 macrophages induced transdifferentiation of ocular
surface fibroblasts to myofibroblasts, as indicated by prominent a-SMA immunostaining
accompanied by increased a-SMA gene expression. Interestingly, M0 macrophages had also
induced transdifferentiation of ocular surface fibroblasts to myofibroblasts and caused increased
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a-SMA gene expression. In addition, our data demonstrates that polarized macrophages
increased fibroblast gene expression of profibrotic mediators. Interestingly, our data shows that
M2 macrophages induced a notable increase in gene expression of RAS components, which is in
tandem with our published data that fibrosis in the conjunctiva is associated with RAS activation
(Shamloo et al., 2021). Chronic GVHD including oGVHD is divided into three phases: 1) early
inflammation and tissue injury; 2) chronic inflammation and dysregulated immune response; and
3) aberrant tissue repair leading to fibrosis (Cooke et al., 2017; Zeiser and Blazar, 2017).
Activation of macrophages, especially the M1 phenotype, during phase 1 inflammatory response
may lead to influx of CD4+ T cells. Earlier studies have demonstrated that macrophages secrete
CCL22, a key chemokine to cause CD4+ T cell influx into the ocular surface in Sjögren’s
disease-associated ocular surface inflammation (Ushio et al., 2018). Studies have also
demonstrated that tumor-infiltrating macrophages can secrete CCL22 to recruit regulatory T
cells, which could lead to suppression of anti-tumor immunity (Martinenaite et al., 2016). Our
data demonstrates that M1 polarized macrophages can secrete large amounts of CCL22, which
could potentially act as a stimulus for T cell infiltration during phase 2 of oGVHD. In fibrotic
conditions, naïve CD4+ T cells have shown to polarize toward the Th2 phenotype, and Th2 cells
secrete cytokines IL-4 and IL-13 that could induce the macrophage milieu to polarize toward the
M2 phenotype. Thus, this interaction between Th2 cells and macrophages could potentially
create a progression from the inflammatory phase to the profibrotic phase in oGVHD (Distler et
al., 2019). Taken together our data provides evidence for the potential role of irradiationmediated activation of macrophages, their phenotypic changes, and their cross talk with other
cells as an underlying mechanism for oGVHD-associated fibrosis.
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CHAPTER 6
CONCLUSION
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Based on the data from the present study in parallel with published literature in nonocular tissues, macrophages could play a key role in the pathology of ocular surface fibrosis
especially in the context of oGVHD. Our data demonstrates that macrophages are activated and
remain viable upon radiation exposure. In addition, our data shows that activated and polarized
macrophages are able to induce profibrotic gene expression in ocular surface fibroblasts and
cause their transdifferentiation to myofibroblasts, therefore serving as a potential mechanism of
oGVHD-associated ocular surface fibrosis.
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APPENDIX
MATERIALS

SUPPLIER

BALB/c Mice

Chapman School of Pharmacy Vivarium

Lysis Buffer

BD Biosciences

Iscove’s Modified Dulbecco’s Medium

Gibco

Antibodies for CD11b, F4/80, CD86, CD206

Thermo Fisher Scientific

Dulbecco’s Modified Eagle Medium

Gibco

Antibodies for a-SMA (primary), Alexa Fluor 488 (secondary)
FACSVerse Flow Cytometer

Invitrogen
BD Biosciences

Confocal Microscopy

Nikon

RNeasy Mini Kit

Qiagen

SuperScript® III First-Strand Synthesis Kit

Invitrogen

Thermocycler

Applied Biosystems

Forward/Reverse Primers of a-SMA, TGF-b1,

Integrated DNA Technologies

Angiotensinogen, ACE, M-CSF, PDGF, CD80, iNOS,
CCL2, IL-1b, CD206, Arginase-1, IL-10, b-actin
Quant3Studio

Applied Biosystems

RS 2000 X-Ray Biological Irradiator

Rad Sources Technologies

Zymosan A Particles

Invitrogen

Alexa Fluor 488-Conjugated Phalloidin

Invitrogen

Annexin V APC Conjugated Apoptosis Assay Kit
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Cayman Chemical
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